Health ❯ Chronic Diseases ❯ Diabetes

Obesity

Hypertension Dementia Cardiovascular Diseases Dietary Interventions Weight Management GLP-1 Receptor Agonists Public Health Implications Smoking Sarcopenia Treatment Options GLP-1 Medications GLP-1 Market Semaglutide-Based Therapies Neurodevelopmental Disorders Cardiometabolic Benefits Breast Cancer Medication Development Health Outcomes Inflammation GLP-1 Agonists Treatment Protocols Drug Treatments Dietary Impact Kidney Transplants Lifestyle Factors Cancer Prevention Health Risks Treatment Innovations Impact of Meal Timing Cardiovascular Risk Risk Factors Heart Failure GLP-1 Treatments Dietary Changes Healthcare Access Medication Effects Weight Loss Drugs

Eli Lilly Spends $3.8 Billion to Build Vaccine Business

Management says the purchases are a long-term hedge funded by strong GLP-1 profits that will not meaningfully change near-term earnings.

RSNA Study Links Muscle Mass, Lower Visceral Fat to Younger 'Brain Age'

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study